B. Lu

Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study

P. Lizotte, C. Dumitru, A. Spira, 2021, Frontiers in Oncology.

T-cell death and cancer immune tolerance

B. Lu, O. Finn, B. Lu, 2008, Cell Death and Differentiation.

Immune checkpoint inhibitors for the treatment of glioblastoma: Where we are

B. Lu, Senxi Du, X. Kong, 2020, Journal of Solid Tumors.